Suven Pharmaceuticals informs about credit rating

28 Feb 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Suven Pharmaceuticals has informed that the CRISIL has assigned/ reaffirmed the ratings to the Bank facilities of the Company as per letter received on February 28, 2025. The said letter is annexed.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

425.65 -15.80 (-3.58%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×